NFKB1 and disease arising from reactivation of latent virus: How HIV-1 suppresses NF-κB activity to establish and maintain latent infection by impacting Naf1, CYLD, or miR-155 needs further investigation, but activating NF-κB activity is an effective “shock and kill” HIV-1 treatment strategy.